✦ LIBER ✦

A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11

✍ Scribed by Koichiro Suemori; Hiroshi Fujiwara; Seiichiro Watanabe; Taichi Azuma; Masaki Yasukawa

Publisher: Carden Jennings Publishing
Year: 2010
Tongue: English
Weight: 173 KB
Volume: 92
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-010-0729-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis of central nervous system le

Prophylaxis of central nervous system leukemia: a case of chronic myeloid leukemia with lymphoid blast crisis treated with imatinib mesylate

✍ Vasantha Thavaraj; Rachna Seth 📂 Article 📅 2008 🏛 SP Children’s Hospital, Zhejiang University School 🌐 English ⚖ 86 KB

Is it possible to discontinue imatinib m

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature

✍ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o